Correlation of Androgen Deprivation Therapy with Cognitive Dysfunction in Patients with Prostate Cancer: A Nationwide Population-Based Study Using the National Health Insurance Service Database
Bum Sik Tae, Byung Jo Jeon, Seung Hun Shin, Hoon Choi, Jae Hyun Bae, Jae Young Park
Cancer Res Treat. 2019;51(2):593-602.   Published online 2018 Jul 18     DOI:
Citations to this article as recorded by Crossref logo
Androgen deprivation therapy for prostate cancer and risk of dementia
David Robinson, Hans Garmo, Mieke Van Hemelrijck, Jan-Erik Damber, Ola Bratt, Lars Holmberg, Lars-Olof Wahlund, Pär Stattin, Jan Adolfsson
BJU International.2019;[Epub]     CrossRef
Investigational luteinizing hormone releasing hormone (LHRH) agonists and other hormonal agents in early stage clinical trials for prostate cancer
Nirmish Singla, Rashed A. Ghandour, Ganesh V. Raj
Expert Opinion on Investigational Drugs.2019; 28(3): 249.     CrossRef
Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis
Omar Saeed, Lori J. Bernstein, Rouhi Fazelzad, Mary Samuels, Lynn A. Burmeister, Lehana Thabane, Shereen Ezzat, David P. Goldstein, Jennifer Jones, Anna M. Sawka
Journal of Cancer Survivorship.2019; 13(2): 231.     CrossRef
Antiaging Therapies, Cognitive Impairment, and Dementia
Devin Wahl, Rozalyn M Anderson, David G Le Couteur
The Journals of Gerontology: Series A.2019;[Epub]     CrossRef